LEVOCARNITINE solution for injection

Strength: 20 mcg/ml; 100 mcg/ml Presentation: ampoules, 0.5 ml (100 mcg/ml); 1 ml (20 mcg/ml & 100 mcg/ml); 2.5 ml (20 mcg/ml) Therapeutic area: Severe peripheral arterial occlusive disease (PAOD) Innovator: Ilomedin (Bayer)

Strength: 10 mcg/ml; 20 mcg/ml Presentation: ampoules, 1 ml & 2 ml Therapeutic area: Pulmonary hypertension Innovator: Ventavis (Bayer)

Strength: 20 mg Iron/ml Presentation: ampoules, 5 ml & vials, 5 ml Therapeutic area: Iron Deficiency Innovator: Venofer (Vifor)

Strength: (50 mcg+5 mg)/ml Presentation: vials, 2.5 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Xalacom (Pfizer)

Strength: 50 mcg/ml Presentation: vial, 2.5 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Xalatan (Pfizer)

Strength: 50 mcg/ml Presentation: vials, 2.5 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Xalatan (Pfizer)

Strength: 5 mg/ml Presentation: vials, 5 ml Therapeutic area: Bacterial external ocular infections Innovator: Oftaquix (Santen)

Strength: 5 mg/ml Presentation: vials, 5 ml Therapeutic area: Bacterial external ocular infections Innovator: Oftaquix (Santen)

Strength: 1 mg/ml Presentation: vials, 5 ml Therapeutic area: Allergic Conjunctivitis Innovator: Opatanol (Alcon)

Strength: 250 mcg/5ml Presentation: vials, 5 ml Therapeutic area: Acute Nausea & Vomiting Innovator: Aloxi (Helsinn Birex)

Strength: 1 mcg/cap; 2 mcg/cap; 4 mcg/cap Therapeutic area: Secondary Hyperparathyroidism Innovator: Zemplar (Abbott)

Strength: 2 mcg/ml; 5 mcg/ml Presentation: ampoules, 1 ml (2 mcg/ml & 5 mcg/ml) & 2 ml (5 mcg/ml); vials, 1 ml (2 mcg/ml & 5 mcg/ml) & 2 ml (5 mcg/ml) Therapeutic area: Secondary Hyperparathyroidism Innovator: Zemplar (Abbott)